Consolidated Statements of Income

in Million Yen or %, Japan GAAP 2019/03 2020/03 2021/03 2022/03
Net Sales 101,520 87,927 97,105 130,702
Costs of goods sold 60,430 53,452 60,190 79,694
Gross Profit on Sales 41,090 34,474 36,914 53,008
Selling, general and administrative expenses 20,869 22,192 21,351 24,681
Operating Profit 20,221 12,282 15,562 28,327
(Operating Profit Margin) 19.9% 14.0% 16.0% 21.7%
Non-operating income 688 255 540 987
Non-operating expenses 104 177 235 153
Recurring Profit 20,805 12,360 15,867 29,160
(Recurring Profit Margin) 20.5% 14.1% 16.3% 22.3%
Extraordinary gains 58 57 1,354 390
Extraordinary losses 419 1,712 1,074 34
Pre-tax Profit 20443 10,705 16,147 29,516
Total income tax and others 5,719 3,598 3,978 8,132
Net Profit before minority interests 14,724 7,106 12,169 21,384
(Net Profit Margin) 14.5% 8.1% 12.5% 16.3%
Net Profit attributable to minority interests 58 -49 -6 57
Net Profit attributable to owners of the parent 14,665 7,156 12,175 21,326

Consolidated Balance Sheet

in Million Yen or %, Japan GAAP 2019/03 2020/03 2021/03 2022/03
ASSETS
　Current Assets 110,094 97,771 111,516 133,829
　Fixed Assets 47,478 48,777 50,039 56,457
　Total Assets 157,573 146,549 161,556 190,287
LIABILITIES
　Current Liabilities 40,948 29,017 39,296 55,641
　Fixed Liabilities 9,220 7,857 5,482 3,564
　Total Liabilities 50,169 36,874 44,778 59,206
NET ASSETS
　Shareholder’s Equity 104,280 107,334 113,487 126,439
　Accumulated other comprehensive income 1,751 1,022 1,881 3,116
　Others 1,361 1,317 1,408 1,524
　Total Net Assets 107,403 109,674 116,777 131,081
Total Liabilities and Net Assets 157,573 146,549 161,556 190,287
(Equity Ratio) 67.3% 73.9% 71.4% 68.1%
(Return on Equity) 14.4% 6.7% 10.9% 17.4%

Consolidated Statements of Cash Flows

in Million Yen or %, Japan GAAP 2019/03 2020/03 2021/03 2022/03
From Operating Activities 12,932 5,965 22,062 23,837
From Investing Activities -13,952 -6,116 -5,191 -8,990
From Financing Activities 5,443 -6,375 -8,282 -10,346

R&D, Capex and Depreciation

in Million Yen 2019/03 2020/03 2021/03 2022/03
R&D Expenditure 7,500 8,234 7,193 8,146
Capital Expenditure 13,900 7,477 5,950 9,793
Depreciation and Amortization 2,655 3,450 3,516 3,551
Amortization of Goodwill 226 41 28 29